Radiation via Monoclonal Antibodies

From Glioblastoma Treatments
Revision as of 21:35, 29 March 2024 by Lazy (talk | contribs) (Created page with "<includeonly> {| class="wikitable" |- ! Property !! Information |- | Drug Name || Radiation via Monoclonal Antibodies |- | FDA Approval || Under research, not yet FDA-approved for general use |- | Used for || Glioblastoma (GBM) and potentially other high-grade glioma tumors |- | Clinical Trial Phase || Various phases, with some treatments in early clinical trials |- | Common Side Effects || Side effects vary depending on the specific monoclonal antibody and radioactive c...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigationJump to search
Retrieved from "http://glioblastomatreatments.wiki:80/index.php?title=Radiation_via_Monoclonal_Antibodies&oldid=322"